1. Home
  2. YEXT vs ZYME Comparison

YEXT vs ZYME Comparison

Compare YEXT & ZYME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YEXT
  • ZYME
  • Stock Information
  • Founded
  • YEXT 2006
  • ZYME 2003
  • Country
  • YEXT United States
  • ZYME United States
  • Employees
  • YEXT N/A
  • ZYME N/A
  • Industry
  • YEXT EDP Services
  • ZYME Biotechnology: Pharmaceutical Preparations
  • Sector
  • YEXT Technology
  • ZYME Health Care
  • Exchange
  • YEXT Nasdaq
  • ZYME Nasdaq
  • Market Cap
  • YEXT 1.1B
  • ZYME 1.2B
  • IPO Year
  • YEXT 2017
  • ZYME 2017
  • Fundamental
  • Price
  • YEXT $8.35
  • ZYME $18.15
  • Analyst Decision
  • YEXT Strong Buy
  • ZYME Buy
  • Analyst Count
  • YEXT 4
  • ZYME 7
  • Target Price
  • YEXT $9.44
  • ZYME $20.00
  • AVG Volume (30 Days)
  • YEXT 1.1M
  • ZYME 651.8K
  • Earning Date
  • YEXT 09-08-2025
  • ZYME 10-30-2025
  • Dividend Yield
  • YEXT N/A
  • ZYME N/A
  • EPS Growth
  • YEXT N/A
  • ZYME N/A
  • EPS
  • YEXT N/A
  • ZYME N/A
  • Revenue
  • YEXT $449,657,000.00
  • ZYME $122,867,000.00
  • Revenue This Year
  • YEXT $8.92
  • ZYME $107.76
  • Revenue Next Year
  • YEXT $5.14
  • ZYME $2.35
  • P/E Ratio
  • YEXT N/A
  • ZYME N/A
  • Revenue Growth
  • YEXT 13.51
  • ZYME 95.94
  • 52 Week Low
  • YEXT $5.51
  • ZYME $9.03
  • 52 Week High
  • YEXT $9.20
  • ZYME $17.70
  • Technical
  • Relative Strength Index (RSI)
  • YEXT 39.53
  • ZYME 71.05
  • Support Level
  • YEXT $8.33
  • ZYME $16.20
  • Resistance Level
  • YEXT $8.55
  • ZYME $17.40
  • Average True Range (ATR)
  • YEXT 0.16
  • ZYME 0.56
  • MACD
  • YEXT -0.04
  • ZYME -0.02
  • Stochastic Oscillator
  • YEXT 4.93
  • ZYME 78.26

About YEXT Yext Inc.

Yext Inc provides a knowledge engine platform that lets businesses manage their digital knowledge in the cloud and sync it to approximately 200 services including Apple Maps, Bing, Cortana, Facebook, Google, Google Maps, Instagram, Siri and Yelp. Digital knowledge is the structured information that a business wants to make publicly accessible. The company also makes search intelligent by helping to provide precise, accurate and current answers to location-based queries that are conducted across the web and mobile applications and voice and artificial intelligence, or AI, engines. The company derives the majority of its revenues from subscription services. Geographically, the company generates a majority of its revenue from North America and the rest from International markets.

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

Share on Social Networks: